₹818.75
+5.55 (+0.68%)
As of 18 Sept 2026, Natco Pharma Ltd share price is ₹818.75. The stock opened at ₹818.75 and had closed at ₹813.20 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹789.30 and a high of ₹1,226.10. In terms of performance, Natco Pharma Ltd share price has decreased by 15.07% over the past six months and has decreased by 8.11% over the last year.
NATCOPHARM Stock Price Chart
Natco Pharma Ltd Overview
Market cap₹14,565 Crs
Volume11,547
Prev. Close₹813.20
Year range₹789.30 - ₹1,226.10
ISININE987B01026
About NATCOPHARM
Natco Pharma is engaged in the business of pharmaceuticals and agricultural chemicals which comprises research and development, manufacturing and selling of bulk drugs, finished dosage formulations.
Natco Pharma Ltd Historical Performance
1 Month Return-8.60%
6 Month Return-14.05%
3 Year Return-8.10%
3 Month Return-4.50%
1 Year Return-4.65%
5 Year Return-11.86%
Natco Pharma Ltd Fundamentals
ROCE(TTM)15.07%
P/E Ratio (TTM)16.33
P/B Ratio1.70
Debt to Equity0.08
ROE14.98%
EPS (TTM)49.80
Dividend Yield0.61%
Book Value477.51
Profit Margin29.75%
Operating Margin23.10%
Natco Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 3,875.70 | 4,415.80 | 3,673.60 | 2,436.50 | 1,862.40 |
| EBITDA | 1,586.00 | 2,465.60 | 1,741.70 | 930.20 | 307.60 |
| Net Profit | 1,281.50 | 1,850.40 | 1,306.60 | 637.10 | 139.10 |
| EPS | 71.55 | 103.31 | 72.79 | 34.90 | 7.63 |
Natco Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 800.03 |
| Resistance 1 (R1) | 827.33 |
| Pivot Point | 814.17 |
Natco Pharma Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 20-Aug-2026 | 14-Aug-2026 | 20-Aug-2026 | Interim | ₹1.50 |
| 18-Feb-2026 | 12-Feb-2026 | 18-Feb-2026 | Interim 3 | ₹1.50 |
| 20-Nov-2025 | 14-Nov-2025 | 20-Nov-2025 | Interim 2 | ₹1.50 |
| 19-Aug-2025 | 12-Aug-2025 | 19-Aug-2025 | Interim 1 | ₹2.00 |
| 18-Feb-2025 | 12-Feb-2025 | 18-Feb-2025 | Interim 3 | ₹1.50 |
NATCOPHARM Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| V C Nannapaneni | Chairman |
| Rajeev Nannapaneni | Chief Executive Officer |
| PSRK Prasad | Executive Director / EVP |
Natco Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Natco Pharma Ltd today is ₹818.75 on NSE and ₹818.75 on BSE.
- The 52-week high of Natco Pharma Ltd is ₹1,226.10, while the 52-week low is ₹789.30.
- The current market capitalisation of Natco Pharma Ltd is approximately ₹14,565 crore.
- The P/E (Price-to-Earnings) ratio of Natco Pharma Ltd is 10.97. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Natco Pharma Ltd is 1.97. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Natco Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for NATCOPHARM on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Natco Pharma Ltd has delivered a return of approximately -8.10%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Natco Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 49.42% promoters, 15.07% FIIs, 5.62% DIIs, and 23.41% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
